Literature DB >> 6557688

Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein.

N Egberg, I Overmark-Berggren.   

Abstract

Determination of factor XII was performed in a test system where plasma samples were diluted (1/400-1/3200) in buffer and factor XII deficient plasma. Diluted CephotestR was used as activator and after 10 min activation time chromogenic substrate H-D-Pro-Phe-Arg-pNA was added. The assay was adopted to an enzyme analyzer. The reproducibility of the method was acceptable with a coefficient of variation of 7.8% in the normal range. The correlation of this method to a one-stage clotting assay for factor XII was good, r 0.79. The preliminary reference interval was calculated to be 52-147% of normal (mean+ 2 S.D.).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6557688     DOI: 10.1016/0049-3848(83)90118-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

2.  Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.

Authors:  M Hellgren; N Egberg; J Eklund
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

3.  Coagulation factor XII protease domain crystal structure.

Authors:  M Pathak; P Wilmann; J Awford; C Li; B K Hamad; P M Fischer; I Dreveny; L V Dekker; J Emsley
Journal:  J Thromb Haemost       Date:  2015-03-11       Impact factor: 5.824

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.